The risk factors for severe patients with COVID-19 in China: A systematic review and meta-analysis
COVID-19 is spreading exponentially. In order to optimize medical resources allocation and reduce mortality, biomarkers are needed to differentiate between COVID-19 patients with or without severe diseases early as possible. We searched Ovid MEDLINE(R), Ovid EMBASE, CNKI, Wanfang, VIP databases, the...
Main Authors: | Xie Yue-liang, Wang Jiang-lin, Yang Hui-qin, Zhou Ge, Deng Hongyu, Fang Wei-jin, Zuo Xiao-cong |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-03-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/20587392211000890 |
Similar Items
-
Prevalence of chronic cough in China: a systematic review and meta-analysis
by: Hanwen Liang, et al.
Published: (2022-02-01) -
Prevalence of depressive symptoms among nurses in China: A systematic review and meta-analysis.
by: Nanzhen Xie, et al.
Published: (2020-01-01) -
The assessment of the quality of reporting of systematic reviews/meta-analyses in diagnostic tests published by authors in China.
by: Long Ge, et al.
Published: (2014-01-01) -
Safety and Efficacy of Low Molecular Weight Heparin for Thromboprophylaxis in the Elderly: A Network Meta-Analysis of Randomized Clinical Trials
by: Hui-qin Yang, et al.
Published: (2021-12-01) -
Laboratory Indicators for Identifying Hand, Foot, and Mouth Disease Severity: A Systematic Review and Meta-Analysis
by: Yaqi Xie, et al.
Published: (2022-10-01)